List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 19 studies with search of:   "Irofulven"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Study of Irofulven in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Irofulven + prednisone;   Drug: Irofulven + capecitabine + prednisone;   Drug: Mitoxantrone + prednisone
2 Active, not recruiting Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
Condition: Liver Cancer
Intervention: Drug: Irofulven + oxaliplatin
3 Completed Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: Irofulven + capecitabine
4 Completed Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer
Condition: Cervical Cancer
Intervention: Drug: irofulven
5 Active, not recruiting Irofulven in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: irofulven
6 Completed Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: irofulven
7 Active, not recruiting Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: fluorouracil;   Drug: irofulven
8 Completed Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: irofulven
9 Completed 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: irofulven
10 Completed Irofulven in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: irofulven
11 Completed Irofulven in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: irofulven
12 Active, not recruiting Irofulven in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: irofulven
13 Completed Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
Condition: Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: irofulven
14 Completed Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: irofulven
15 Completed Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Drug: irofulven
16 Active, not recruiting Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: irofulven
17 Completed 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: irofulven
18 Active, not recruiting Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: irofulven
19 Completed Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: irofulven

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services